Endocyte, Inc. (NASDAQ Global Market: ECYT), and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Endocyte (ECYT) Prices 17.86M Share Common Offering at $4.20/ShFebruary 28, 2018 9:20 AM Endocyte (ECYT) Announces Proposed Common Share OfferingFebruary 28, 2018 5:45 AM Cowen Sees Favorable Risk/Reward in Endocyte (ECYT) Amid Phase III Trial of PSMA-617February 27, 2018 3:33 PM Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION TrialFebruary 26, 2018 11:43 AM Endocyte (ECYT) Reports Update on Phase 3 VISION Trial February 26, 2018 8:05 AM